Related Experiment Video
Updated: Aug 10, 2026
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
[Neurological manifestations of Behçet's disease]
B Wechsler1, A Sbaï, L T H Du-Boutin
1Service de Médecine Interne, 47-83 Bd de l'Hôpital, Paris Cedex 13, France.
Revue Neurologique
|October 31, 2002
Summary
Neurological complications in Behçet's Disease, including vascular and central nervous system issues, can be severe. Early treatment with steroids and immunosuppressants significantly improves outcomes and reduces relapses.
Area of Science:
- Neurology
- Immunology
- Vascular Medicine
Context:
- Behçet's Disease (BD) is a multisystem inflammatory disorder.
- Neurological complications affect 5-35% of BD patients, impacting prognosis.
- Understanding these neurological manifestations is crucial for effective management.
Purpose:
- To review the spectrum of neurological complications in Behçet's Disease.
- To discuss diagnostic findings, including neuroimaging and cerebrospinal fluid analysis.
- To evaluate treatment strategies and their impact on patient outcomes.
Summary:
- Neurological involvement in Behçet's Disease encompasses vascular (cerebral venous thrombosis, arterial issues) and parenchymal (meningoencephalitis, myelitis) manifestations.
- Neuroimaging (MRI) reveals characteristic hypersignals, while CSF analysis often shows abnormalities.
- While initially responsive to treatment, relapses can lead to severe disability.
Impact:
- Aggressive therapy combining steroids, immunosuppressants, and colchicine improves both short-term and long-term prognosis.
- Adherence to treatment significantly reduces relapse rates in patients with Behçet's Disease.
- Optimized management strategies are essential to mitigate the severe long-term consequences of neuro-Behçet's.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Related Concept Videos
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...